Ovulation Testing Kits Global Market Report 2024

The ovulation testing kits market size has grown rapidly in recent years. It will grow from $2.74 billion in 2023 to $3.02 billion in 2024 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to the rising trend of family planning, increased fertility awareness, growing emphasis on women's health, growing demand for accurate ovulation testing kits and expanding the availability of over-the-counter options.

The ovulation testing kits market size is expected to see rapid growth in the next few years. It will grow to $4.49 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. The projected growth in the forecast period is driven by several factors, including the expanding global population, rising birth rates, increased incidence of fertility challenges and delayed childbirth, greater adoption of digital health solutions and mobile applications, growing awareness and acceptance of at-home fertility testing, and improved healthcare accessibility in emerging economies. Key trends anticipated during this period encompass personalized fertility tracking solutions, integration of artificial intelligence for ovulation prediction, the introduction of wearable fertility trackers, environmentally friendly and sustainable options for ovulation testing, and the utilization of telemedicine and remote monitoring for fertility care.

The anticipated rise in the ovulation testing kits market is linked to decreasing fertility rates. Fertility rates indicate the number of live births within a population over a specified timeframe, usually represented as births per 1,000 women aged 15-49 annually. Factors contributing to declining fertility rates include increased educational and career opportunities for women, enhanced access to and utilization of contraceptives, postponed marriage and childbearing, and elevated living expenses. Ovulation testing kits play a crucial role for individuals or couples contending with reduced fertility rates, providing a non-invasive and accessible means to optimize the timing of intercourse and enhance the likelihood of conception. For instance, data from the Office for National Statistics in February 2024 revealed a decline in the total fertility rate (TFR) to 1.49 children per woman in 2022, down from 1.55 children per woman in 2021. Hence, declining fertility rates are propelling the ovulation testing kits market's growth.

Major players in the ovulation testing kits market are concentrating on forging strategic alliances to gain a competitive advantage. These strategic alliances involve collaborative endeavors among key industry stakeholders aimed at bolstering market presence, broadening product portfolios, and leveraging emerging prospects. They encompass partnerships, joint ventures, collaborations, and agreements among manufacturers, distributors, healthcare providers, and other relevant entities to achieve shared goals and foster market expansion. For example, in November 2022, Innova Medical Group, a US-based healthcare entity specializing in COVID-19 antigen tests, teamed up with iXensor, a Taiwan-based company offering a mobile health diagnosis platform, to introduce the 'PHRONESIA Smart Ovulation Test,' an intelligent ovulation testing solution. This test integrates PixoTech technology and leverages iXensor's expertise. PixoTech technology holds promise in meeting the escalating demand for intelligent at-home testing through collaborations with lateral flow assay manufacturers, pharmaceutical firms, and MedTech innovators.

In October 2021, Everly Health, a digital health platform company headquartered in Austin, acquired Natalist for an undisclosed sum. This acquisition is geared toward enhancing Everly Health's foothold in the fertility and pregnancy sector, expanding its array of offerings to assist individuals in their path to parenthood. Natalist, a direct-to-consumer reproductive health startup based in the United States, offers various products, including ovulation testing kits.

Major companies operating in the ovulation testing kits market are Church & Dwight Co Inc, Piramal Enterprises Inc., Meril Diagnostics Pvt Ltd, Roman Health Ventures Inc, BIOSYNEX SA, Boditech Med Inc., Mankind Pharma Ltd., Innovita Biological Technology Co., Ltd., Hangzhou Clongene Biotech Co., Ltd., Swiss Precision Diagnostics GmbH, Artron Laboratories Inc., Wondfo Biotech Co., Ltd., AdvaCare Pharma, Proov, Shanghai Chemtron Biotech Co., Ltd., Apollo Pharmacy Pvt. Ltd., Ava Science Inc., Clinical Guard Ltd., Fairhaven Health LLC, Femometer Ltd., iProven, Megna Health Inc., Easy Healthcare Corporation (Premom), Biotrol Laboratories Private Limited, Tulip Diagnostics Pvt. Ltd.

North America was the largest region in the ovulation testing kits market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ovulation testing kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ovulation testing kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ovulation testing kits are diagnostic devices crafted to assist individuals in pinpointing the most fertile days of their menstrual cycle by detecting the surge in luteinizing hormone (LH) that occurs before ovulation. These kits are frequently employed by couples seeking to conceive to determine the best timing for intercourse, thereby enhancing the chances of pregnancy. Serving as valuable aids in family planning, these kits provide a non-intrusive and simple means to comprehend and leverage the body's natural fertility cues.

The primary categories of ovulation testing kits include urine-based, saliva-based, and salivary ferning kits. Urine-based kits utilize hormonal changes in urine to forecast ovulation. They are available through various distribution channels such as pharmacies, drugstores, hypermarkets, supermarkets, e-commerce platforms, and others. These kits cater to diverse end users including hospitals, clinics, diagnostic centers, fertility centers, home care settings, and others.

The ovulation testing kits market research report is one of a series of new reports that provides ovulation testing kits market statistics, including the ovulation testing kits industry global market size, regional shares, competitors with ovulation testing kits market share, detailed ovulation testing kits market segments, market trends, and opportunities, and any further data you may need to thrive in the ovulation testing kits industry. This ovulation testing kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ovulation testing kits market consists of sales of digital ovulation predictor kits, combination kits, fertility monitors, and ovulation prediction wearables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.